Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna
    Italy
    letizia.polito@unibo.it
    GJCT

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


    More Info.
    Manzoor Ahmad Rather
    Division of Medicinal Chemistry
    Indian Institute of Integrative Medicine
    India
    manzooriiim@gmail.com
    GJCT

    Research Interest: Drug Discovery and Development from Plant Sources. Isolation and Characterization of Bioactive Molecules from High Altitude Medicinal and Aromatic Plants Using Different Separation Techniques Like TLC, Column Chromatography, Preparative TLC, HPLC, HPTLC, LC-MS, GC-FID And GC-MS. Characterization of the Isolated Molecules from the Plants Using Different Spectroscopic Techniques Like 1H NMR, 13C NMR, 2D Techniques, Mass Spectrometry, IR, X-Ray, UV- Visible Etc. Structural Modifications of these Molecules to Value Add their Biological Properties. Chemical Characterization Using Capillary GC-FID and GC-MS Analytical Techniques and Bioevaluation of Essential Oils, Oleoresins and Other Aroma Mixtures Isolated from Aromatic Plants with Main Thrust on Unexplored Flora of the Kashmir Valley

    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    analivia_sg@yahoo.com.br
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    Abdel-Moneim Osman
    Professor
    Department of Medicine
    King Abdel-Aziz University
    Saudi Arabia
    moneimosman@hotmail.com
    GJCT
    Research Interest: Cancer Research.Pharmacology, Cell Cycle Effect, Drug-Drug Intertaction, Chemoprotection, Potentiation olf Cytotoxic Drugs
    More Info.
    Ryou-U Takahashi
    Division of Molecular and Cellular Medicine
    National Cancer Center Research Institute
    Japan
    rytakaha@ncc.go.jp
    GJCT

    Research Interest: Molecular And Cell Biology, Microrna, Breast Cancer, Cancer Stem Cells


    More Info.
    Muzafar Ahmad Macha
    Department of Biochemistry
    Molecular Biology University Nebraska Medical Center
    USA
    muzafar.macha@unmc.edu
    GJCT

    Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


    More Info.
    Fan Song
    Sun Yat-Sen University
    China
    fansong8888@163.com
    GJCT

    Research Interest: Minimal Invasion, Endoscopically Assisted Selective Neck Dissection, Functional Reconstruction, Mitochondrial Fission, Cisplatin Sensitivity, Mirna, Lncrna


    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Patrizio Lancellotti
    Professor
    Cardiology
    University of Liege
    Belgium
    plancellotti@chu.ulg.ac.be
    GJCT

    Research Interest: New Insights Into The Development And Progression Of Aortic Valvestenosis (Thenid-¬‐PAS Study) Progression And Outcome Of Secondary Mitral Regurgitation (POMAR Registry)Radiation-¬‐Induced Heart Disease (AVRI Study): Animal Study Normal Reference Ranges For Echocardiography: Rationale, Study Design And Methodology(NORRE Study)


    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    eselze82@gmail.com
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Julius Strauss
    Associate Investigator
    National Cancer Institute
    Thomas Aquinas College
    USA
    julius.strauss@nih.gov
    GJCT

    Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

    More Info.
    Vessela Vassileva
    Research Associate
    Department of Surgery & Cancer
    UCL Cancer Institute
    UK
    vessie_vassileva@hotmail.com
    GJCT

    Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    View more
    mendeley

    Clinical trials cannot provide sufficient accuracy for studying weak factors necessary for curing chronic diseases

    DOI Logo 10.17352/2581-5407.000044

    Published On: March 23, 2022 | Pages: 021 - 033

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View
    mendeley

    Surgery, Chemotherapy and Radiotherapy May Promote Cancer Growth Speeds and Shorten Patient Lives

    DOI Logo 10.17352/2581-5407.000043

    Published On: March 19, 2022 | Pages: 001 - 020

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View
    mendeley

    Patient’s experiences on receiving radiation therapy for head and neck cancer pre, pending and post treatment: A qualitative study at Bugando medical centre Mwanza, Tanzania

    DOI Logo 10.17352/2581-5407.000042

    Published On: August 23, 2021 | Pages: 046 - 049

    Author(s): Francis Kazoba* and Juston John
    Abstract View Full Article View    
    mendeley

    Assessment of the role of multimodality imaging for treatment volume definition of intracranial ependymal tumors: An original article

    DOI Logo 10.17352/2581-5407.000041

    Published On: July 06, 2021 | Pages: 043 - 045

    Author(s): Ferrat Dincoglan, Omer Sager*, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology

    DOI Logo 10.17352/2581-5407.000040

    Published On: May 19, 2021 | Pages: 035 - 042

    Author(s): Benjamin A Babalola*, Gboyega E Adebami and Samuel E Akinsuyi
    Abstract View Full Article View    
    mendeley

    Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)

    DOI Logo 10.17352/2581-5407.000039

    Published On: March 15, 2021 | Pages: 031 - 034

    Author(s): Omer Sager*, Ferrat Dincoglan, Selcuk Demiral and Murat Beyzadeoglu
    Abstract View Full Article View    
    mendeley

    Essentially new inhibitors of metastasis of malignant tumors for chemotherapy-sparing treatment

    DOI Logo 10.17352/2581-5407.000038

    Published On: February 24, 2021 | Pages: 016 - 030

    Author(s): ISh Nadiradze* and NSh Chigogidze
    Abstract View Full Article View    
    mendeley

    Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma

    DOI Logo 10.17352/2581-5407.000037

    Published On: February 13, 2021 | Pages: 010 - 015

    Author(s): Amany R Keruakous*, Silas Day and Carrie Yuen
    Abstract View Full Article View    
    mendeley

    Application of nano based drug delivery channel against leukemia chemotherapeutic resistance

    DOI Logo 10.17352/2581-5407.000036

    Published On: February 09, 2021 | Pages: 001 - 009

    Author(s): Rahul Bhattacharjee*, Olabimtan Olabode H, Ochigbo Victor and Samuel Florence
    Abstract View Full Article View    
    mendeley

    Atypical Fibroadenoma Presentation of a Case

    DOI Logo 10.17352/2581-5407.000035

    Published On: November 10, 2020 | Pages: 042 - 044

    Author(s): Juana Teresa Santiago Pérez*, José Miguel González Barcena, Yuranis Gárciga Martin and Yahumara Suarez Morales
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT

    Google Reviews 11